XML 83 R29.htm IDEA: XBRL DOCUMENT v3.22.1
Stockholders’ Equity (Details Narrative) - USD ($)
1 Months Ended 12 Months Ended
Dec. 20, 2021
Dec. 31, 2021
Dec. 31, 2021
Dec. 31, 2020
Sep. 10, 2021
Apr. 30, 2021
Dec. 31, 2016
Subsidiary, Sale of Stock [Line Items]              
Common stock, shares authorized   200,000,000 200,000,000 20,000,000      
Preferred stock, shares authorized   10,000,000 10,000,000 0      
Preferred stock, par value   $ 0.0001 $ 0.0001 $ 0.0001      
Gross proceeds from issuance of shares     $ 18,648,934        
Net proceeds from issuance of shares   $ 18,648,934          
Common Stock, Par or Stated Value Per Share   $ 0.0001 $ 0.0001 $ 0.0001      
Options granted to purchase common stock     1,029,000      
Options exercise price     $ 1.60      
Stock options weighted average remaining contractual term     10 years        
Share based payment award, vesting, description     The options vest in equal monthly installments beginning on the grant date ranging from 24 to 48 months        
Expected and contractual life     10 years        
Voltalit rate, minimum     117.00%        
Voltality rate, maximum     128.00%        
Dividend rate     0.00%        
Risk free interest rate, minimum     1.37%        
Risk free interest rate, maximum     1.74%        
Share price   $ 0.83 $ 0.83        
Share based compensation     $ 159,983        
Intrinsic value option vested   $ 1,079,254 1,079,254        
Intrinsic value outstanding   $ 2,671,341 $ 2,671,341        
Class of Warrant or Right, Number of Securities Called by Warrants or Rights           156,000  
Class of Warrant or Right, Exercise Price of Warrants or Rights   $ 3.93 $ 3.93   $ 0.80  
Minimum [Member]              
Subsidiary, Sale of Stock [Line Items]              
Options exercise price     0.80        
Maximum [Member]              
Subsidiary, Sale of Stock [Line Items]              
Options exercise price     $ 1.86        
Officer [Member]              
Subsidiary, Sale of Stock [Line Items]              
Options granted to purchase common stock     736,500        
Director [Member]              
Subsidiary, Sale of Stock [Line Items]              
Options granted to purchase common stock     292,500        
2016 Plan [Member]              
Subsidiary, Sale of Stock [Line Items]              
Number of shares available for grant   1,761,120 1,761,120       417,120
2021 Plan [Member]              
Subsidiary, Sale of Stock [Line Items]              
Number of shares available for grant         900,000    
2016 Plan and 2021 Plan [Member]              
Subsidiary, Sale of Stock [Line Items]              
Number of shares available for grant         1,340,136    
Common Stock [Member]              
Subsidiary, Sale of Stock [Line Items]              
Stock issued during period shares new issues     4,200,000        
Gross proceeds from issuance of shares     $ 420        
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures 20,000            
Common Stock, Par or Stated Value Per Share $ 5.00            
Stock Issued During Period, Value, Issued for Services $ 59,000            
Warrant [Member]              
Subsidiary, Sale of Stock [Line Items]              
Intrinsic value option vested   $ 430,560 430,560        
Intrinsic value outstanding   $ 430,560 430,560        
IPO [Member]              
Subsidiary, Sale of Stock [Line Items]              
Stock issued during period shares new issues 4,200,000            
Shares offered at a price $ 5.00            
Gross proceeds from issuance of shares $ 21,000,000            
Payment for debt issuance cost $ 2,351,066            
Net proceeds from issuance of shares     $ 18,648,934        
Debt conversion, shares issued 5,633,689            
Class of Warrant or Right, Number of Securities Called by Warrants or Rights   210,000 210,000        
Class of Warrant or Right, Exercise Price of Warrants or Rights   $ 6.25 $ 6.25